Clinical Trial Update: Cytomegalovirus (CMV) Specific Cytotoxic T Lymphocytes (CTL) When Used for Prophylaxis Against CMV in Recipients of Allogeneic, T Cell Depleted Stem Cell Transplants [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating CMV-specific cytotoxic T lymphocytes for CMV prophylaxis in recipients of allogeneic, T-cell depleted stem cell transplants; the study …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cytomegalovirus Infection

Drugs mentioned

• CMV-specific cytotoxic T lymphocytes

Snippet

Sponsor: Milton S. Hershey Medical Center | Conditions: Cytomegalovirus Infections | Phase 1 | Status: COMPLETED